Journal profile · ONCOLOGY
International Cancer Conference Journal
ISSN 2192-3183 · 4 issues per year
International Cancer Conference Journal: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.4 (journal website); hybrid open access; APC about USD 4,090; median 100 days to acceptance (101 articles, last 24 months); 97 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
International Cancer Conference Journal is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Sarcoma Diagnosis and Treatment, Ovarian cancer diagnosis and treatment and Cancer Immunotherapy and Biomarkers, together about 18.9% of its articles. Its main subfields are Pulmonary and Respiratory Medicine and Oncology. (generated from OpenAlex topic counts and CAS ranking data)
This peer-reviewed online-only journal publishes original case reports on all types of cancer, together with literature reviews on related or similar cases. In particular, we welcome not only case reports of educational value in the diagnosis and treatment of cancers, but also reports on cancer cases involving molecular analysis and concerning e.g. gene mutations, gene fusions, gene expression, and changes in copy number, regardless of their known clinical significance. Deciding how to conduct the molecular analysis of a tumor usually requires a “cancer conference” in which experts from various fields discuss it. Even if the authors and their respective “cancer conference” were unable to determine the clinical significance of molecular changes at the time of submission and publication, their data may provide evidence that will help the scientific community develop targeted medicine solutions in the future. International Cancer Conference Journal is the official quarterly publication of the Japan Society of Clinical Oncology (JSCO). - Presents an online-only collection of original case reports, together with literature reviews on all types of cancer - In particular, welcomes cancer cases involving molecular analysis - The Official Publication of the Japan Society of Clinical Oncology (JSCO)
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY
Editor-in-chief Hidetoshi EguchiPublisher website
Editorial board by country: none in mainland China; most named Japan 22 (22 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Sarcoma Diagnosis and TreatmentMedicine7.1%
- Ovarian cancer diagnosis and treatmentMedicine6.4%
- Cancer Immunotherapy and BiomarkersMedicine5.5%
- Renal cell carcinoma treatmentMedicine5.4%
- Gastric Cancer Management and OutcomesMedicine5.4%
- Neuroendocrine Tumor Research AdvancesMedicine5.2%
- Cancer Diagnosis and TreatmentMedicine4.5%
- Lung Cancer Research StudiesMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCILetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbasePublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 0.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 0.5Publisher website ·
- h-index
- 15OpenAlex ·
- i10-index
- 49OpenAlex ·
- 2-year mean citedness
- 0.88OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 12.24%LetPub ·
Volume
- Articles per year
- 94LetPub ·
- Downloads per year (publisher) 2025
- 117,400Publisher website ·
Articles by year OpenAlex count · 913 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 79 | 77 | 15 |
| 2025 | 97 | 97 | 79 |
| 2024 | 97 | 96 | 147 |
| 2023 | 51 | 51 | 89 |
| 2022 | 64 | 64 | 179 |
| 2021 | 68 | 68 | 235 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
100 daysMedian, submission to acceptance · P25–P75 69 days – 132 days
- Acceptance to online
- median 18 days (101 articles)
- Submission to online
- median 123 days
- Sample
- 101 articles with submission and acceptance dates (192 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 7 daysPublisher website ·
- Peer review
- Single anonymous peer review, Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,090 / EUR 3,090 / GBP 2,690 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Page charges
- No page charges
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Keywords
- ≥ 3
- Manuscript length
- ≤ 3,000 words
- Reference style
- Numbered, in order of citation
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Cover letter
- Required
- Not considered
- Review articles
Article types accepted10, with length limits
- brief communicationManuscripts may be submitted to the International Journal of Cancer Conference (ICCJ) in the form of case reports (usually accompanied by a literature review), …Length not stated
- case reportManuscripts may be submitted to the International Journal of Cancer Conference (ICCJ) in the form of case reports (usually accompanied by a literature review), …main text ≤ 3,000 words
- case reportsManuscripts may be submitted to the International Journal of Cancer Conference (ICCJ) in the form of case reports (usually accompanied by a literature review), …Length not stated
- editorialManuscripts may be submitted to the International Journal of Cancer Conference (ICCJ) in the form of case reports (usually accompanied by a literature review), …Length not stated
- letterManuscripts may be submitted to the International Journal of Cancer Conference (ICCJ) in the form of case reports (usually accompanied by a literature review), …Length not stated
- letters to the editorManuscripts may be submitted to the International Journal of Cancer Conference (ICCJ) in the form of case reports (usually accompanied by a literature review), …main text ≤ 500 words
- literature reviewManuscripts may be submitted to the International Journal of Cancer Conference (ICCJ) in the form of case reports (usually accompanied by a literature review), …Length not stated
- review articleManuscripts may be submitted to the International Journal of Cancer Conference (ICCJ) in the form of case reports (usually accompanied by a literature review), …Length not stated
- review articlesExternally submitted review articles will not be considered for publication. Only review articles solicited by the society or the editorial board will be eligib…Length not stated
- video articlesVideo articles are brief communications describing a novel surgical technique or a standardized procedure for oncology cases with an accompanying abstract and m…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
Originality and exclusivity of submissions Model summary
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Competing Interests
Conflict of interest disclosure required Model summary
Authors are requested to disclose interests that are directly or indirectly related to the work submitted for publication. Interests within the last 3 years of beginning the work (conducting the research and preparing the work for submission) should be reported. Interests outside the 3-year time frame must be disclosed if they could reasonably be perceived as influencing the submitted work. Disclo…
Source ↗Publisher website ·- Data availability Data availability statement:
Data availability statement required Model summary
All original research must include a data availability statement. See “Research Data Policy and Data Availability Statements” below. Other statements such as ethics approval, informed consent, and authors’ contribution statements may also be included. References Formatting must conform to the styles described in the “References” section below.Figure caption should be included in the text file of t…
Source ↗Publisher website ·- Publication ethics
Patient consent for identifiable information Model summary
Information that may identify patients, including names, initials, or hospital numbers should not be included in videos unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication.
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide.
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in International Cancer Conference Journal, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review
Single-blind peer review Model summary
This journal follows a single-blind reviewing procedure, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to the authors are anonymous.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Frequency
- 4 issues per year
- ISSN
- 2192-3183
- Society / sponsor
- Japan Society of Clinical Oncology
- Latest issue on the website
- Volume 15, Issue 3 (July 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
FAQ
Frequently asked questions about International Cancer Conference Journal
What CAS zone is International Cancer Conference Journal in?
In the 2025 upgraded edition of the CAS Journal Ranking, International Cancer Conference Journal is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of International Cancer Conference Journal?
The journal's website gives an impact factor of 0.4 (2025); this is the journal's own figure, as LetPub lists none for it; h-index 15.
How long does peer review take at International Cancer Conference Journal?
Based on the dates recorded on 101 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 100 days (interquartile range 69–132 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of International Cancer Conference Journal?
According to the journal's author guidelines: Keywords: ≥ 3; Manuscript length: ≤ 3,000 words; Reference style: Numbered, in order of citation; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of International Cancer Conference Journal based?
Of the 22 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Japan (22). Counted from the institutions listed on the board page; for reference only.
Which databases index International Cancer Conference Journal?
According to LetPub and DOAJ records, International Cancer Conference Journal is indexed in ESCI. The journal's website also lists Embase; that list has not been checked against each database.
Is International Cancer Conference Journal open access, and what is the APC?
International Cancer Conference Journal is a hybrid journal. For open-access publication: APC about USD 4,090.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .